PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print    Next page > 
     
Internationally Acclaimed Forensic Scientist Dr. Henry C. Lee Dies, Leaving Remarkable Legacy
WEST HAVEN, Conn. , March 28, 2026 /PRNewswire/ -- World-renowned forensic scientist Dr. Henry C. Lee passed away peacefully on Friday, March 27, at his home in Henderson, Nevada, displaying remarkable ...
2026-03-28T    Biotechnology   Computer/Electronics   Education   Health Care/Hospital 
Akeso Reports Full-Year 2025 Financial Results
HONG KONG , March 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive, strategic leaps ...
2026-03-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million
CAMBRIDGE, Mass. , March 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Keymed Biosciences Announces 2025 Annual Results and Business Updates
BEIJING , March 26, 2026 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. The year marked the company's 10th anniversary and a pivotal year in its transition from R&D ...
2026-03-26T    Biotechnology   Health Care/Hospital 
CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
Key Highlights: ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
C-Ray Therapeutics and SHINE Technologies Enter Strategic Partnership for Exclusive Distribution of No-Carrier-Added Lu-177 in Mainland China
CHENGDU, China and JANESVILLE, Wis. , March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of a Master Radioisotope Supply ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards
Reinforcing long-term commitment to embedding sustainability across operations and partnerships Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innovent Announces 2025 Annual Results and Business Updates
From China Leadership to Global Premier: ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala
- First regulatory clearance in Latin America marks a strategic milestone for regional market expansion - World's first antibiotic-free manufacturing process ensures superior safety profile ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alphamab Oncology Reports Full Year 2025 Financial Results and Business Highlights
SUZHOU, China , March 26, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2025 and highlighted recent business progr ...
2026-03-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.